✦ LIBER ✦

Muir-Torre syndrome associated with endometrial carcinoma

✍ Scribed by Toshimitsu Tohya; Takeshi Ogura; Kengo Nishi; Hazuki Nishi; Kazumi Kuriwaki

Publisher: Springer
Year: 2008
Tongue: English
Weight: 286 KB
Volume: 13
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-008-0783-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Muir—Torre syndrome with multiple neopla

Muir—Torre syndrome with multiple neoplasia

✍ Dr F. Cruz Vigo; R. Pardo; D. Saenz; T. Fernandez; O. Leiva 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views

Muir-Torre syndrome in patients with hem

Muir-Torre syndrome in patients with hematologic malignancies

✍ Philip R. Cohen 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

Incidence of cutaneous sebaceous carcino

Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms : Insight into Muir-Torre syndrome

✍ Graça M. Dores; Rochelle E. Curtis; Jorge R. Toro; Susan S. Devesa; Joseph F. Fr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

Muir-Torré syndrome in a patient with ac

Muir-Torré syndrome in a patient with acquired immunodeficiency syndrome

✍ J. Graells; J. Marcoval; A. Badell; J. Notario; X. Fulladosa 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

Pathologic features of endometrial carci

Pathologic features of endometrial carcinoma associated with HNPCC : A comparison with sporadic endometrial carcinoma

✍ Russell R. Broaddus; Henry T. Lynch; Lee-may Chen; Molly S. Daniels; Peggy Conra 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 556 KB

Endometrial carcinoma associated with br

Endometrial carcinoma associated with breast carcinoma: Low incidence with tamoxifen use

✍ Rosa E. Cuenca; Juan Giachino; Mark A. Arredondo; Ronald Hempling; Stephen B. Ed 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 524 KB

## BACKGROUND. Women treated with tamoxifen for breast cancer are at increased risk of endometrial cancer. This study examines the experience at Roswell Park Cancer Institute (RPCI) with women diagnosed with both endometrial carcinoma (EC) and breast carcinoma (BC) to determine the risk and stage